Y-mAbs

YTD

ALL

Why Robinhood?

You can watch Y-mAbs and buy or sell other stocks, ETFs, and their options commission-free!

About YMAB

Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory.

CEO

Michael Rossi

CEOMichael Rossi

Employees

107

Employees107

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

2015

Founded2015

Employees

107

Employees107

YMAB Key Statistics

Market cap

391.22M

Market cap391.22M

Price-Earnings ratio

-17.40

Price-Earnings ratio-17.40

Dividend yield

—

Dividend yield—

Average volume

128.38K

Average volume128.38K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$16.11

52 Week high$16.11

52 Week low

$3.55

52 Week low$3.55

People also own

Based on the portfolios of people who own YMAB. This list is generated using Robinhood data, and it’s not a recommendation.